Targeting innovation in antibiotic drug discovery and development: the need for a One Health–One Europe–One World Framework (2016)

Edited by: Matthew J Renwick, Victoria Simpkin and Elias Mossialos
Observatory Studies Series No. 45
2016, viii + 126 pages
ISBN 978 92 890 5040 1
CHF 40.00/US$ 48.00
In developing countries: CHF 28.00/US$ 33.60
Order no. 13400173

Antimicrobial resistance is a global crisis that threatens public health and modern medicine. The discovery and development of novel antibiotic products are critical components in combating it. Many international, European Union and national initiatives address the scientific, regulatory and economic barriers to antibiotic innovation. This study identifies, reviews and critically assesses these initiatives, and provides policy recommendations for improving the global and European agendas for research and development of antibiotics.